# FDA Inspection 1020725 - RXQ Compounding LLC - August 08, 2017

Source: https://www.keypedia.com/records/fda_inspections/rxq-compounding-llc/80f95709-8b1d-4cf2-997c-e5507ba56e1e
Source feed: FDA_Inspections

> FDA Inspection 1020725 for RXQ Compounding LLC on August 08, 2017. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1020725
- Company Name: RXQ Compounding LLC
- Inspection Date: 2017-08-08
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 942763 - 2015-09-21](https://www.keypedia.com/records/fda_inspections/rxq-compounding-llc/67430ba2-c193-49b9-8714-e1ad1582f95b)

Company: https://www.keypedia.com/companies/rxq-compounding-llc/acf60274-80ce-4e6c-8ecf-25eed581d137

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c